Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
conteltinib (SY-707)
i
Other names:
SY-707, CT 707, CT-707
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Centaurus Biopharma, Shouyao Holdings
Drug class:
ALK inhibitor, Multi-tyrosine kinase inhibitor, IGF-1R inhibitor, FAK inhibitor, Pyk2 inhibitor
Related drugs:
‹
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
repotrectinib (27)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
TQ-B3101 (6)
APG-2449 (4)
TPX-0131 (4)
envonalkib (3)
TGRX-326 (3)
AZD3463 (2)
NVL-655 (1)
SY-3505 (1)
ALK inhibitor (0)
ASP-3026 (0)
CEP-37440 (0)
TY-2136b (0)
ZG0418 (0)
TSR-011 (0)
XZP-3621 (0)
sorafenib (180)
anlotinib (139)
ponatinib (98)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
donafenib (2)
AMG 706 (2)
HA121-28 (1)
CT053PTSA (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
TAS-115 (0)
BMS-754807 (10)
AMG 479 (10)
ASP7487 (7)
GSK 1838705A (2)
CP-751,871 (1)
BMS-536924 (0)
FPI-1434 (0)
IGV-001 (0)
KW-2450 (0)
LX-101 (0)
NVP-ADW742 (0)
NVP-AEW541 (0)
NVP-TAE226 (0)
teprotumumab-trbw (0)
XL228 (0)
IMC A12 (0)
MK 0646 (0)
MEDI-573 (0)
MM-141 (0)
AXL1717 (0)
SCH 717454 (0)
VS-6063 (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
IN10018 (3)
GSK2256098 (1)
PF-562271 (1)
FAK-JAK 2 dual Inhib (0)
PF-573228 (0)
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
repotrectinib (27)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
TQ-B3101 (6)
APG-2449 (4)
TPX-0131 (4)
envonalkib (3)
TGRX-326 (3)
AZD3463 (2)
NVL-655 (1)
SY-3505 (1)
ALK inhibitor (0)
ASP-3026 (0)
CEP-37440 (0)
TY-2136b (0)
ZG0418 (0)
TSR-011 (0)
XZP-3621 (0)
sorafenib (180)
anlotinib (139)
ponatinib (98)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
donafenib (2)
AMG 706 (2)
HA121-28 (1)
CT053PTSA (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
TAS-115 (0)
BMS-754807 (10)
AMG 479 (10)
ASP7487 (7)
GSK 1838705A (2)
CP-751,871 (1)
BMS-536924 (0)
FPI-1434 (0)
IGV-001 (0)
KW-2450 (0)
LX-101 (0)
NVP-ADW742 (0)
NVP-AEW541 (0)
NVP-TAE226 (0)
teprotumumab-trbw (0)
XL228 (0)
IMC A12 (0)
MK 0646 (0)
MEDI-573 (0)
MM-141 (0)
AXL1717 (0)
SCH 717454 (0)
VS-6063 (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
IN10018 (3)
GSK2256098 (1)
PF-562271 (1)
FAK-JAK 2 dual Inhib (0)
PF-573228 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ALK positive
Non Small Cell Lung Cancer
ALK positive
Non Small Cell Lung Cancer
SY-707
Sensitive: C2 – Inclusion Criteria
SY-707
Sensitive
:
C2
SY-707
Sensitive: C2 – Inclusion Criteria
SY-707
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login